Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Profit Margin (Quarterly): -857.7% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -857.7% |
| March 31, 2024 | -1.52K% |
| December 31, 2023 | -1.14K% |
| September 30, 2023 | 25.09% |
| June 30, 2023 | -3.07K% |
| March 31, 2023 | -1.42K% |
| December 31, 2022 | -1.43K% |
| September 30, 2022 | -339.3% |
| June 30, 2022 | -1.92K% |
| March 31, 2022 | -2.03K% |
| December 31, 2021 | -2.09K% |
| September 30, 2021 | -367.0% |
| June 30, 2021 | -812.1% |
| March 31, 2021 | -4.25K% |
| December 31, 2020 | |
| September 30, 2020 | -404.4% |
| June 30, 2020 | -26.32% |
| March 31, 2020 | -1.45K% |
| December 31, 2019 | -1.69K% |
| September 30, 2019 | -1.14K% |
| June 30, 2019 | -688.5% |
| March 31, 2019 | |
| December 31, 2018 | -993.8% |
| September 30, 2018 | |
| June 30, 2018 | -728.8% |
| Date | Value |
|---|---|
| March 31, 2018 | -1.00K% |
| December 31, 2017 | -1.04K% |
| September 30, 2017 | -110.3% |
| June 30, 2017 | -946.1% |
| March 31, 2017 | -33.92% |
| December 31, 2016 | 27.95% |
| September 30, 2016 | -78.07% |
| June 30, 2016 | -1.23K% |
| March 31, 2016 | -1.15K% |
| December 31, 2015 | 41.16% |
| September 30, 2015 | -705.2% |
| June 30, 2015 | -1.08K% |
| March 31, 2015 | -876.3% |
| December 31, 2014 | -999.0% |
| September 30, 2014 | 28.99% |
| June 30, 2014 | -1.11K% |
| March 31, 2014 | 33.94% |
| December 31, 2013 | -1.41K% |
| September 30, 2013 | -1.49K% |
| June 30, 2013 | -4.35K% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -1.56% |
| June 30, 2012 | 36.01% |
| March 31, 2012 | 54.61% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.25K%
Minimum
Mar 2021
25.09%
Maximum
Sep 2023
-1.36K%
Average
-1.42K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 29.46% |
| Eli Lilly and Co | 26.25% |
| Altimmune Inc | -492.8K% |
| Genmab AS | 26.06% |
| Viking Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.55% |
| Return on Assets | -17.88% |
| Return on Invested Capital | -19.92% |
| Gross Profit Margin (Quarterly) | 72.20% |
| Operating Margin (Quarterly) | -784.3% |
| Return on Net Operating Assets | -192.7% |